Hetero has elevated Chandra Shekhar, Ph.D., to the position of President – Research & Development (R&D), recognising his extensive experience and contributions to pharmaceutical research, development and innovation.
In his new role, Chandra Shekhar will bring his expertise in active pharmaceutical ingredients (APIs), process development, product development and commercialisation to strengthen Hetero’s research and development capabilities.
Prior to this elevation, he served as Senior Vice President – R&D API at Hetero. He has also held senior research and development leadership positions at Lupin, including Head of Process Research & Development and Vice President – New Product Development.
Earlier in his career, he spent over two decades at Dr. Reddy’s Laboratories, where he progressed through various leadership roles in integrated product development and API research. He also served as a Postdoctoral Research Associate at the Massachusetts Institute of Technology (MIT).
His elevation reflects Hetero’s continued focus on strengthening its R&D leadership and advancing pharmaceutical innovation, process optimisation and product development.

